Cargando…

Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis

BACKGROUND: CXCL12/CXCR4 transactivation of epidermal growth factor family receptors in lipid raft membrane microdomains on cell surface is thought to mediate tumor growth and subsequent development of metastatic disease. CTCE-9908 is a known inhibitor of CXCR4. Herein, we tested the efficacy of CTC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Donald, Kandagatla, Pridvi, Korz, Walter, Chinni, Sreenivasa R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912255/ https://www.ncbi.nlm.nih.gov/pubmed/24472670 http://dx.doi.org/10.1186/1471-2490-14-12

Ejemplares similares

PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling
por: Conley-LaComb, M Katie, et al.
Publicado: (2013)

Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis
por: Conley-LaComb, M. Katie, et al.
Publicado: (2016)

Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth
por: Govindarajan, Barani, et al.
Publicado: (2023)

Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth
por: Govindarajan, Barani, et al.
Publicado: (2023)

Technology to accelerate pangenomic scanning for unknown point mutations in exonic sequences: cycling temperature capillary electrophoresis (CTCE)
por: Ekstrøm, Per O, et al.
Publicado: (2007)

Sonographic Assessment of Intravascular Fluid Estimate (SAFE) Score by Using Bedside Ultrasound in the Intensive Care Unit
por: Killu, Keith, et al.
Publicado: (2020)

A novel cross-talk between CXCR4 and PI4KIIIα in prostate cancer cells.
por: Sbrissa, Diego, et al.
Publicado: (2018)

Novel lipid mediators contributing to androgen receptor therapy resistance in prostate cancer
por: Chinni, Sreenivasa R.
Publicado: (2021)

Meta-Analysis of the Relationship between CXCR4 Expression and Metastasis in Prostate Cancer
por: Lee, Joo Yong, et al.
Publicado: (2014)

Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis
por: Hernandez, Lorena, et al.
Publicado: (2011)

CXCR3 as a molecular target in breast cancer metastasis: inhibition of tumor cell migration and promotion of host anti-tumor immunity
por: Zhu, Guiquan, et al.
Publicado: (2015)

Self-assembly of CXCR4 antagonist peptide–docetaxel conjugates for breast tumor multi-organ metastasis inhibition
por: Li, Chen, et al.
Publicado: (2023)

Scavenging of CXCL12 by CXCR7 Promotes Tumor Growth and Metastasis of CXCR4-positive Breast Cancer Cells
por: Luker, Kathryn E., et al.
Publicado: (2012)

TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model
por: Semaan, Louie, et al.
Publicado: (2019)

Inhibition of CXCR4 Enhances the Efficacy of Radiotherapy in Metastatic Prostate Cancer Models
por: Gupta, Nisha, et al.
Publicado: (2023)

The dynamic yin-yang interaction of CXCR4 and CXCR7 in breast cancer metastasis
por: Hawkins, Oriana E, et al.
Publicado: (2012)

CXCR4-Targeted Radiopharmaceuticals for the Imaging and Therapy of Malignant Tumors
por: Yu, Jingjing, et al.
Publicado: (2023)

Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate Cancer
por: Di Mitri, Diletta, et al.
Publicado: (2019)

Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer
por: Heidegger, Isabel, et al.
Publicado: (2022)

CXCR7 regulates breast tumor metastasis and angiogenesis in vivo and in vitro
por: Qian, Tingting, et al.
Publicado: (2018)

CXCR2: A Novel Mediator of Mammary Tumor Bone Metastasis
por: Sharma, Bhawna, et al.
Publicado: (2019)

Inhibition of CXCR4 and CXCR7 Is Protective in Acute Peritoneal Inflammation
por: Ngamsri, Kristian-Christos, et al.
Publicado: (2020)

Mifepristone inhibits ovarian cancer metastasis by intervening in SDF-1/CXCR4 chemokine axis
por: Zheng, Ning, et al.
Publicado: (2017)

Targeting CXCL12/CXCR4 Signaling with AMD3100 Might Selectively Suppress CXCR4+ T-Cell Chemotaxis Leading to the Alleviation of Chronic Prostatitis
por: Zhang, Meng, et al.
Publicado: (2022)

Improving the inhibitory effect of CXCR4 peptide antagonist in tumor metastasis with an acetylated PAMAM dendrimer
por: Liu, Changliang, et al.
Publicado: (2018)

Nef-M1, a CXCR4 Peptide Antagonist, Enhances Apoptosis and Inhibits Primary Tumor Growth and Metastasis in Breast Cancer
por: Bumpers, Harvey, et al.
Publicado: (2013)

Targeting the CXCR4/CXCL12 axis with the peptide antagonist E5 to inhibit breast tumor progression
por: Guo, Hua, et al.
Publicado: (2017)

Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti–PD-L1 immunotherapy
por: Li, Zhaoting, et al.
Publicado: (2020)

CXCR4 Expression in Prostate Cancer Progenitor Cells
por: Dubrovska, Anna, et al.
Publicado: (2012)

HPMA Copolymer CXCR4 Antagonist Conjugates Substantially Inhibited the Migration of Prostate Cancer Cells
por: Peng, Zheng-Hong, et al.
Publicado: (2014)

Overexpression of CXCR7 accelerates tumor growth and metastasis of lung cancer cells
por: Liu, Huan, et al.
Publicado: (2020)

Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling Axis
por: Shanmugam, Muthu K., et al.
Publicado: (2018)

Saikosaponin A Inhibits Triple-Negative Breast Cancer Growth and Metastasis Through Downregulation of CXCR4
por: Wang, Ying, et al.
Publicado: (2020)

MTSS1 inhibits colorectal cancer metastasis by regulating the CXCR4/CXCL12 signaling axis
por: Chen, Lei, et al.
Publicado: (2021)

MTSS1 inhibits colorectal cancer metastasis by regulating the CXCR4/CXCL12 signaling axis
por: Chen, Lei, et al.
Publicado: (2023)

GLI1 orchestrates CXCR4/CXCR7 signaling to enhance migration and metastasis of breast cancer cells
por: Inaguma, Shingo, et al.
Publicado: (2015)

Targeting SDF-1/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas
por: Tseng, D, et al.
Publicado: (2011)

RNAi targeting CXCR4 inhibits proliferation and invasion of esophageal carcinoma cells
por: Wang, Tao, et al.
Publicado: (2013)

Targeting CXCR4 in AML and ALL
por: Cancilla, Daniel, et al.
Publicado: (2020)

CXCR4-targeted theranostics in oncology
por: Buck, Andreas K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mjngbjkuo8b75lhklevd5ng5ir